Tilray® Signs Global Collaboration Agreement with Leading Pharmaceutical Company NANAIMO, British Columbia, December 18, 2018–(BUSINESS WIRE)–Tilray Canada Ltd., a subsidiary of Tilray Inc. (NASDAQ: TLRY), a global pioneer in...

Sandoz Canada Becomes the First Canadian Pharmaceutical Company to Enter the Medical Cannabis Field Boucherville, June 19, 2018 (GLOBE NEWSWIRE) — Sandoz Canada and Tilray finalize alliance to provide...

Tilray® Forms Strategic Alliance with Leading Pharmaceutical Company in Canada Agreement represents major milestone recognizing medical cannabis as a conventional medicine for patients in need March 19, 2018 TORONTO–(BUSINESS...